Roche gets U.S. approval for hospital glucose monitor
ZURICH (Reuters) - The Food and Drug Administration (FDA) has given clearance for Roche's new blood glucose monitor for hospital testing, the Swiss drugmaker said.
Roche, which earlier on Tuesday reported strong third quarter sales, said its ACCU-CHEK Inform II system allowed real-time wireless transfer of patient data between hospital medical staff and the laboratory.
The FDA clearance was the third for a diabetes product this year for Roche, the world leader in the blood glucose monitoring market with its Accu-Chek brand.
(Reporting by Caroline Copley)
- Air strike kills 15 civilians in Yemen by mistake: officials
- Pope attacks mega-salaries and wealth gap in peace message
- North Korea says Jang Song Thaek, uncle of leader Kim Jong Un, executed
- Probation for drunk Texas teen driver who killed four sparks backlash
- North Korea executes leader's powerful uncle in rare public purge |
Thousands line up to say goodbye to Nelson Mandela, whose body is lying in state in Pretoria. Slideshow